Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05505552 · ClinicalTrials.gov registry record · NA
Effects of Vitamin K on Lower-extremity Function in Adults With Osteoarthritis:
A NA study of Osteo Arthritis Knee, sponsored by Tufts University.
- Active
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 3
- Study locations
NCT05505552 is a NA study of Osteo Arthritis Knee that is active but no longer recruiting, run by Tufts University. The registered enrollment target is 37 participants, below the 137-participant average among 22 other Osteo Arthritis Knee trials with a reported enrollment target (73% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT05505552, a NA study of Osteo Arthritis Knee, is active but no longer recruiting, sponsored by Tufts University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 3
- Study locations
Study Summary
The overall goal of this pilot randomized trial is to obtain necessary prerequisite data to conduct a randomized controlled intervention to test the effect of vitamin K supplementation on knee osteoarthritis progression and related functional decline. To address critical parameters required to design this larger RCT, we will conduct a double-blind, 2-armed, parallel-group intervention study, with a placebo run-in, in which 50 adults with mild to moderate knee OA and low baseline vitamin K status will be randomly assigned to 1 mg phylloquinone/day or matching placebo, and treated for 6 months. Specifically, we will: (1) compare the effects of 1 mg/day phylloquinone vs. placebo on the non-functional circulating form of MGP; (2) estimate rates of recruitment and retention, follow-up rates and reasons for loss to follow-up, response rates to questionnaires, adherence/compliance rates, and potential for site differences; and (3) determine the responsiveness of the Osteoarthritis Research Society International (OARSI)-recommended performance-based tests of physical function in adults with low vitamin K status and mild to moderate knee osteoarthritis. We will also obtain preliminary data on the distribution of MGP genotype at two clinical sites for effect size generation. As of February 2025, based on attrition rate below what was initially expected, we revised our planned enrollment from 50 to 35, to achieve the original goal of 30 completers. This was approved by the study sponsor.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Vitamin K
Study Locations (3)
Massachusetts
- Tufts University - Boston
- UMass Memorial Medical Center - Worcester
North Carolina
- University of North Carolina Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2023-09-20 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05505552
The ClinicalTrials.gov registry entry for NCT05505552 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 137-participant average among 22 other Osteo Arthritis Knee trials with a reported enrollment target (73% lower). The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteo Arthritis Knee appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05505552 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, North Carolina.
Frequently Asked Questions
What is clinical trial NCT05505552 about?
NCT05505552 is a clinical study titled "Effects of Vitamin K on Lower-extremity Function in Adults With Osteoarthritis:". The overall goal of this pilot randomized trial is to obtain necessary prerequisite data to conduct a randomized controlled intervention to test the effect of vitamin K supplementation on knee osteoarthritis progression and related functional decline. To address critical parameters required to desig...
What is the current status of trial NCT05505552?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 37 participants. The study started on 2023-09-20. Estimated completion is 2026-12-31.
What conditions does trial NCT05505552 study?
This clinical trial studies the following conditions: Osteo Arthritis Knee.
What interventions are being tested in trial NCT05505552?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Vitamin K (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05505552?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05505552 being conducted?
This trial has 3 study locations across Massachusetts, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteo Arthritis Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gait Rehabilitation to Treat FastOA
RECRUITING · NA
-
Effects of Home Base Whole-body Vibration in Osteoarthritis. (VIBE-Rx2)
RECRUITING · NA
-
Optimizing Pain Self-Management in Total Knee Arthroplasty
RECRUITING · NA
-
MISHA Post-Market Clinical Study
RECRUITING · NA
-
Bone Marrow Aspirate Concentrate (BMAC)Treatment for Knee Osteoarthritis
RECRUITING · NA
-
Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.